Nestlé's Volume Push Gets a 90-Basis-Point Punishment as Cocoa Relief Offers Little Immediate Comfort

Nestlé Q1 organic growth slowed to 3.5% after costly infant formula recall, with shares near 200-day MA; cocoa cost relief and portfolio pruning offer cautious optimism.

Philipp Navratil, Nestlé’s chief executive, has made volume-driven growth the centrepiece of his turnaround playbook. The ambition collided with reality in the first quarter: a costly recall of infant formula sliced an estimated 90 basis points off organic sales growth, leaving the reported figure at a modest 3.5%. Though internal real growth — a measure of actual product volumes — eked out a 1.2% gain, developed-market demand remained tepid, underscoring how fragile the recovery remains. Reported revenues dropped 5.7% to CHF 21.3 billion, pummelled by currency headwinds that continue to distort the top line.

The stock’s performance mirrors that uncertainty. At Wednesday’s close of €83.72, Nestlé’s shares sat just centimetres above their 200-day moving average of €83.04 but well below the 50-day line of €86.73. Over the past twelve months the equity has surrendered roughly 7% of its value. Raiffeisen Bank International analysts point out that while the valuation is historically cheap, a debt ratio north of 60% severely cramps upside. Morningstar, nevertheless, estimates the stock trades at a 12% discount to fair value, and the broader analyst consensus carries a target of CHF 87.87. One critical variable is whether the balance-sheet drag can ease as margins recover.

On the cost side, there is reason for cautious optimism. The cocoa price has tumbled more than 50% from a year ago, recently settling at $4,417 a tonne after a 3.7% weekly drop. Confectionary is a substantial profit centre for Nestlé, but the benefit will only trickle through gradually because many raw-material contracts were hedged at higher levels. Operating margin relief may become more visible in the second half, especially as supply chains in the Nutrition business normalise. Currency movements remain a wild card: the strong Swiss franc is still shaving value off earnings reported in francs.

Navratil is also pruning the portfolio to sharpen the focus. The planned sale of a majority stake in Blue Bottle Coffee to Centurium Capital fits a broader strategy of exiting capital-intensive retail while retaining brand-adjacent products — Nespresso capsules carrying the Blue Bottle name will stay in the fold. Alongside a strong quarter for coffee and pet food, the move signals a shift from price-led growth to genuine volume expansion. Management insists the full-year guidance of 3% to 4% organic expansion and an improved margin is intact.

Income-oriented shareholders are eyeing the dividend. After CHF 3.10 per share last year, analysts pencil in a modest increase to CHF 3.14, continuing a long record of progressive pay-outs. The next operational check-in arrives in July with second-quarter numbers. Until then, Nestlé looks like a stock trapped between real cost tailwinds and a punishing debt-and-recall overhang, waiting for the scale to tip.